• Home
  • Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab.

Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab.

Author List
Cummings SR, McCulloch C
Publication
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Publication ID (Profile URL)
https://researcherprofiles.org/profile/103202865
Publication Year
2020
PubMed ID
32246168
Publication Title
Cummings SR, McCulloch C. Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab. Osteoporos Int. 2020 06; 31(6):1019-1021.